130 results
Page 3 of 7
424B5
qdf4ei
27 Apr 22
Prospectus supplement for primary offering
6:30am
8-K
EX-10.1
yy9lih6w 92v69d2t9
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
8-K
s99s eg82vosb
15 Mar 22
Agile Therapeutics Announces $4.85 Million Registered Direct Offering
5:03pm
424B5
x71ajzcc 9hcax
14 Mar 22
Prospectus supplement for primary offering
5:26pm
424B5
vci220 x2avlx8
10 Jan 22
Prospectus supplement for primary offering
8:00am
PRE 14A
u8oui7v
22 Nov 21
Preliminary proxy
4:45pm
424B5
odi3wtho
8 Oct 21
Prospectus supplement for primary offering
5:21pm
424B5
33ipxv
7 Oct 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
mnl6yy5ozcqf1k1v567
10 Sep 21
Regulation FD Disclosure
4:31pm
8-K
EX-99.1
4w63ebxpo66n3x4p
4 May 21
Agile Therapeutics Reports First Quarter 2021 Financial Results
4:10pm